AA
KNSA icon

ALPS Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

ALPS Advisors’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-28,203
Closed -$556K – 981
2024
Q1 		$556K Sell
28,203
-13,693
-33% -$267K ﹤0.01% 580
2023
Q4 		$735K Sell
41,896
-29,207
-41% -$480K 0.01% 547
2023
Q3 		$1.24M Buy
71,103
+19,709
+38% +$332K 0.01% 404
2023
Q2 		$724K Buy
+51,394
New +$688K 0.01% 551
2021
Q4 		– Sell
-83,983
Closed -$957K – 933
2021
Q3 		$957K Buy
83,983
+41,412
+97% +$539K 0.01% 396
2021
Q2 		$593K Sell
42,571
-14,659
-26% -$223K 0.01% 498
2021
Q1 		$1.06M Buy
57,230
+603
+1% +$12.3K 0.01% 392
2020
Q4 		$1M Buy
+56,627
New +$995K 0.01% 390
2019
Q4 		– Sell
-38,173
Closed -$325K – 839
2019
Q3 		$325K Sell
38,173
-1,600
-4% -$17.7K ﹤0.01% 803
2019
Q2 		$539K Sell
39,773
-4,795
-11% -$74.4K ﹤0.01% 511
2019
Q1 		$805K Buy
44,568
+8,115
+22% +$157K 0.01% 380
2018
Q4 		$1.02M Buy
36,453
+8,560
+31% +$179K 0.01% 299
2018
Q3 		$711K Buy
27,893
+6,491
+30% +$126K ﹤0.01% 465
2018
Q2 		$371K Buy
+21,402
New +$387K ﹤0.01% 813

Other funds holding KNSA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ALPS Advisors's KNSA Position: Q2 2024 in Review

ALPS Advisors sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2024, closing a stake of 28,203 shares — an estimated $556K sold.

ALPS Advisors first reported a position in KNSA in Q2 2018 and held it in 14 quarters. The position peaked at $1.24M in Q3 2023. 133 funds tracked by Wall St. Rank hold KNSA as of Q2 2024.

  • ALPS Advisors reported no remaining Kiniksa Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • ALPS Advisors sold 28,203 Kiniksa Pharmaceuticals shares in Q2 2024, an estimated $556K.
  • ALPS Advisors first reported a position in Kiniksa Pharmaceuticals in Q2 2018 and held it in 14 quarters.
  • ALPS Advisors's Kiniksa Pharmaceuticals position peaked at $1.24M in Q3 2023.
  • 133 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2024.

Based on ALPS Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.